PAP

Persistent Asset Partners Portfolio holdings

AUM $258M
1-Year Est. Return 159.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+159.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
+$70M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
392
New
Increased
Reduced
Closed

Top Buys

1 +$8.43M
2 +$5.15M
3 +$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

1 +$4.82M
2 +$3.15M
3 +$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

1 Healthcare 56.04%
2 Technology 14.52%
3 Financials 12.06%
4 Communication Services 4.8%
5 Energy 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOR icon
226
Vor Biopharma
VOR
$862M
$141K 0.07%
+10,798
NAMS icon
227
NewAmsterdam Pharma
NAMS
$4.41B
$138K 0.07%
+3,948
KPTI icon
228
Karyopharm Therapeutics
KPTI
$200M
$135K 0.06%
+18,316
NKE icon
229
Nike
NKE
$62.7B
$134K 0.06%
2,100
-225
COHR icon
230
Coherent
COHR
$79B
$129K 0.06%
+700
TVTX icon
231
Travere Therapeutics
TVTX
$4.14B
$126K 0.06%
+3,291
AVGO icon
232
Broadcom
AVGO
$1.97T
$125K 0.06%
+360
BE icon
233
Bloom Energy
BE
$82.4B
$121K 0.06%
1,397
-2,789
AVR
234
Anteris Technologies
AVR
$635M
$116K 0.06%
23,317
DBVT
235
DBV Technologies
DBVT
$1.16B
$115K 0.06%
+6,019
CERT icon
236
Certara
CERT
$745M
$113K 0.05%
+12,791
MLTX icon
237
MoonLake Immunotherapeutics
MLTX
$1.36B
$112K 0.05%
+8,523
ADPT icon
238
Adaptive Biotechnologies
ADPT
$2.1B
$109K 0.05%
+6,689
BLTE
239
Belite Bio
BLTE
$6.14B
$108K 0.05%
+673
BBOT
240
BridgeBio Oncology
BBOT
$647M
$107K 0.05%
+8,585
FSLR icon
241
First Solar
FSLR
$25.2B
$103K 0.05%
393
-307
SRZN icon
242
Surrozen
SRZN
$350M
$98.5K 0.05%
+4,359
EYPT icon
243
EyePoint Inc
EYPT
$1.13B
$98.4K 0.05%
+5,387
XRAY icon
244
Dentsply Sirona
XRAY
$2.09B
$98.4K 0.05%
+8,605
INSW icon
245
International Seaways
INSW
$4.22B
$97.1K 0.05%
+2,000
CSTL icon
246
Castle Biosciences
CSTL
$550M
$95.8K 0.05%
+2,463
ENVA icon
247
Enova International
ENVA
$4.06B
$95.6K 0.05%
+608
DNLI icon
248
Denali Therapeutics
DNLI
$3.14B
$93.6K 0.05%
+5,670
NVST icon
249
Envista
NVST
$3.89B
$92.6K 0.04%
+4,264
PRQR icon
250
ProQR Therapeutics
PRQR
$179M
$91.2K 0.04%
45,154
+8,874